These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31786978)

  • 1. Evolution of a New Class of Antihypertensive Drugs: Targeting the Brain Renin-Angiotensin System.
    Llorens-Cortes C; Touyz RM
    Hypertension; 2020 Jan; 75(1):6-15. PubMed ID: 31786978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain ACE2 activation following brain aminopeptidase A blockade by firibastat in salt-dependent hypertension.
    Hmazzou R; Marc Y; Flahault A; Gerbier R; De Mota N; Llorens-Cortes C
    Clin Sci (Lond); 2021 Mar; 135(6):775-791. PubMed ID: 33683322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central antihypertensive effects of orally active aminopeptidase A inhibitors in spontaneously hypertensive rats.
    Marc Y; Gao J; Balavoine F; Michaud A; Roques BP; Llorens-Cortes C
    Hypertension; 2012 Aug; 60(2):411-8. PubMed ID: 22710644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orally Active Aminopeptidase A Inhibitor Prodrugs: Current State and Future Directions.
    Keck M; Hmazzou R; Llorens-Cortes C
    Curr Hypertens Rep; 2019 May; 21(7):50. PubMed ID: 31115779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Brain Aminopeptidase A: A New Strategy for the Treatment of Hypertension and Heart Failure.
    Marc Y; Boitard SE; Balavoine F; Azizi M; Llorens-Cortes C
    Can J Cardiol; 2020 May; 36(5):721-731. PubMed ID: 32389345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new strategy for treating hypertension by blocking the activity of the brain renin-angiotensin system with aminopeptidase A inhibitors.
    Gao J; Marc Y; Iturrioz X; Leroux V; Balavoine F; Llorens-Cortes C
    Clin Sci (Lond); 2014 Aug; 127(3):135-48. PubMed ID: 24697296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central antihypertensive effects of chronic treatment with RB150: an orally active aminopeptidase A inhibitor in deoxycorticosterone acetate-salt rats.
    Marc Y; Hmazzou R; Balavoine F; Flahault A; Llorens-Cortes C
    J Hypertens; 2018 Mar; 36(3):641-650. PubMed ID: 28968260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the brain renin-angiotensin system in hypertension: implications for new treatment.
    Marc Y; Llorens-Cortes C
    Prog Neurobiol; 2011 Oct; 95(2):89-103. PubMed ID: 21763394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NI956/QGC006, a Potent Orally Active, Brain-Penetrating Aminopeptidase A Inhibitor for Treating Hypertension.
    Keck M; De Almeida H; Compère D; Inguimbert N; Flahault A; Balavoine F; Roques B; Llorens-Cortes C
    Hypertension; 2019 Jun; 73(6):1300-1307. PubMed ID: 31067198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure.
    Reaux A; Iturrioz X; Vazeux G; Fournie-Zaluski MC; David C; Roques BP; Corvol P; Llorens-Cortes C
    Biochem Soc Trans; 2000; 28(4):435-40. PubMed ID: 10961935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of firibastat in combination with enalapril and hydrochlorothiazide on blood pressure and vasopressin release in hypertensive DOCA-salt rats.
    Marc Y; Hmazzou R; De Mota N; Balavoine F; Llorens-Cortes C
    Biomed Pharmacother; 2021 Aug; 140():111682. PubMed ID: 34020248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised, double-blind, placebo-controlled, dose-escalating phase I study of QGC001, a centrally acting aminopeptidase a inhibitor prodrug.
    Balavoine F; Azizi M; Bergerot D; De Mota N; Patouret R; Roques BP; Llorens-Cortes C
    Clin Pharmacokinet; 2014 Apr; 53(4):385-95. PubMed ID: 24337978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Firibastat: An Oral First-in-Class Brain Aminopeptidase A Inhibitor for Systemic Hypertension.
    Khosla J; Aronow WS; Frishman WH
    Cardiol Rev; 2022 Jan-Feb 01; 30(1):50-55. PubMed ID: 33027067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension.
    Fournie-Zaluski MC; Fassot C; Valentin B; Djordjijevic D; Reaux-Le Goazigo A; Corvol P; Roques BP; Llorens-Cortes C
    Proc Natl Acad Sci U S A; 2004 May; 101(20):7775-80. PubMed ID: 15136730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension.
    Bodineau L; Frugière A; Marc Y; Inguimbert N; Fassot C; Balavoine F; Roques B; Llorens-Cortes C
    Hypertension; 2008 May; 51(5):1318-25. PubMed ID: 18362226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Knowledge about the New Drug Firibastat in Arterial Hypertension.
    Hansen E; Grimm D; Wehland M
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain renin-angiotensin system blockade with orally active aminopeptidase A inhibitor prevents cardiac dysfunction after myocardial infarction in mice.
    Boitard SE; Marc Y; Keck M; Mougenot N; Agbulut O; Balavoine F; Llorens-Cortes C
    J Mol Cell Cardiol; 2019 Feb; 127():215-222. PubMed ID: 30599150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Firibastat: a Novel Treatment for Hypertension.
    Nesbitt SD
    Curr Hypertens Rep; 2021 Dec; 23(12):46. PubMed ID: 34950965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminopeptidase A inhibitors as centrally acting antihypertensive agents.
    Bodineau L; Frugière A; Marc Y; Claperon C; Llorens-Cortes C
    Heart Fail Rev; 2008 Sep; 13(3):311-9. PubMed ID: 18175217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of angiotensin III in hypertension.
    Reaux-Le Goazigo A; Iturrioz X; Fassot C; Claperon C; Roques BP; Llorens-Cortes C
    Curr Hypertens Rep; 2005 Apr; 7(2):128-34. PubMed ID: 15748538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.